STRATEGIES FOR OUTPATIENT MONITORING AND FOLLOW-UP OF ENDOMETRIOID OVARIAN CYSTS
Main Article Content
Abstract
Endometrioid ovarian cysts (endometriomas or chocolate cysts) represent one of the most common and severe manifestations of endometriosis, affecting 10–15% of women of reproductive age and leading to significant clinical problems such as chronic pelvic pain, infertility, and reduced quality of life. This article is devoted to outpatient (polyclinic-based) monitoring and follow-up strategies for endometrioid ovarian cysts, focusing on effective methods for symptom management without invasive interventions, as well as early detection of cyst growth and potential complications.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009.
2. Lee HJ, Yoon SH, Lee JH, et al. Clinical evaluation and management of endometriosis: 2024 guideline for Korean patients from the Korean Society of Endometriosis. Obstet Gynecol Sci. 2025;68(1):43-58. doi:10.5468/ogs.24242.
3. American College of Obstetricians and Gynecologists (ACOG). Management of ovarian cysts. ACOG Practice Bulletin. Updated 2024. Available at: https://www.acog.org/clinical/clinical-guidance/practice-bulletin.
4. National Institute for Health and Care Excellence (NICE). Endometriosis: diagnosis and management. NICE guideline [NG73]. Updated 2023. Available at: https://www.nice.org.uk/guidance/ng73.
5. Flyckt R, Kim S, Falcone T. Pathophysiology and Clinical Implications of Ovarian Endometriomas. Semin Reprod Med. 2024;42(2):1-12. doi:10.1055/s-0044-1786145.
6. Guillot M, Aubry G, Lavoué V, et al. Natural history of ovarian endometrioma in pregnancy and postpartum: a systematic review. Ultrasound Obstet Gynecol. 2024;63(2):156-164. doi:10.1002/uog.27412.
7. Muzii L, Galati G, Di Tucci C, et al. Medical management of ovarian endometriomas: a systematic review and network meta-analysis. Fertil Steril. 2023;119(3):412-422. doi:10.1016/j.fertnstert.2022.12.034.
8. Pateman K, Mavrelos D, Ultraound study of natural progression of ovarian endometrioma. Ultrasound Obstet Gynecol. 2024;64(2):178-185. doi:10.1002/uog.28371.
9. Working group of ESGE, ESHRE and WES. Recommendations for the surgical treatment of endometriosis. Part 2: ovarian endometrioma. Hum Reprod Open. 2022;2022(1):hoab041. doi:10.1093/hropen/hoab041.
10. American College of Radiology (ACR). Appropriateness Criteria®: Clinically Suspected Adnexal Mass, No Acute Symptoms. J Am Coll Radiol. 2023;20(11S):S349-S367. doi:10.1016/j.jacr.2023.08.012.
11. Somigliana E, Viganò P, Vigano P, et al. Expectant management of ovarian endometriomas: a systematic review and meta-analysis. Reprod Biomed Online. 2024;48(5):103456. doi:10.1016/j.rbmo.2024.103456.
12. Vercellini P, Ottolini F, Frattaruolo MP, et al. Long-term medical management of endometriomas: progestins versus combined oral contraceptives. J Clin Endocrinol Metab. 2023;108(8):1987-1995. doi:10.1210/clinem/dgad145.